Global /Cayman Islands /Healthcare /Drug Manufacturers - Specialty & Generic /900120
chevron_leftBack

CXI Healthcare Technology Group Ltd.

900120
KRX: 900120 Delayed
54KRW -1.8%
0.0378 USD
As of 24 April 2025, CXI Healthcare Technology Group Ltd. has a market cap of $11.52M USD, ranking #32453 globally and #25 in Cayman Islands. It ranks #3252 in the Healthcare sector, and #682 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
32453
Country Rank
25
Sector Rank
3252
Industry Rank
682
Key Stats
Market Cap
$11.52MUSD
16.53B KRW
Enterprise Value
-$131.1MUSD
-187.14B KRW
Revenue (TTM)
$46.47MUSD
66.71B KRW
EBITDA (TTM)
$29.67MUSD
42.36B KRW
Net Income (TTM)
$19.3MUSD
27.71B KRW
EBITDA Margin
63%
Profit Margin
42%
PE Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jin Lin open_in_new
Employees
10
Founded
2009
Website
ckhfnh.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% -3.6% 5.7% -16% -39% -52%
Upcoming Earnings
Earnings Date
Fri, May 30

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
900120
CXI Healthcare Technology Group Ltd
ISIN: KYG2114A1094
Shares Out.:
300.578M1 Shares Float: 217.09M2
TV:
SA:
YF:
GF:
BA:
MS:
54 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About CXI Healthcare Technology Group Ltd.

CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It primarily offers Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 and is based in Grand Cayman, the Cayman Islands.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
584K%
Merck KGaA
MRK
$59.42B
52.43B EUR
516K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
427K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
402K%
Haleon plc
HLN
$45.57B
34.34B GBP
396K%